Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.475
+0.065 (1.47%)
Jul 21, 2026, 3:42 PM EDT - Market open
Arbutus Biopharma Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Arbutus Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $5.12. The average 1-year stock price forecast is 14.41% higher than the current stock price, while the lowest is $4.87 (+8.83%) and the highest is $5.38 (+20.22%).
Price Target: $5.12 (+14.41%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Arbutus Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Financial Forecast
Revenue This Year
181.40M
from 14.08M
Increased by 1,188.06%
Revenue Next Year
2.70M
from 181.40M
Decreased by -98.51%
EPS This Year
-0.16
from -0.17
EPS Next Year
-0.05
from -0.16
EPS and Forward PE are based on non-GAAP adjusted numbers.